Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-15

FDA Approved: GLIMEPIRIDE — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approves a supplemental application for glimepiride from Micro Labs Limited, authorizing a generic version of the diabetes medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)